About
Stephen Thompson is a founding Partner of Brandon Capital Partners. Previously Stephen worked with Bio Innovation SA and helped establish Terra Rossa Capital, a dedicated life science Fund Manager in Adelaide. Prior to this Stephen was a Director of Apax Partners a leading international private equity group based in London. During this time Stephen was also a Director of Imperial Innovations, the commercialisation company of Imperial College London. Before joining Apax Partners, Stephen fulfilled roles in product development with UK biotechnology company Cantab Pharmaceuticals. Earlier, Stephen spent ten years as a research immunologist in London and California. Stephen is a Member of the Board of Directors at Elastagen P/L, MiReven P/L, Vaxxas P/L, Helmedix P/L, Auspherix P/L and Council Member of the Australian Venture Capital Association Limited (AVCAL). Stephen has an Honours degree in Immunology and Biochemistry, a Ph.D. in Immunology from Kings College London and an M
Position in the VCSift Database
- • 2,531 investors hold the Partner role in VCSift. Stephen Thompson is one of them.
- • 705 investors are based in Melbourne, Victoria, Australia.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Melbourne, Australia
Contact Information
Find more investors like Stephen
Search Investors